Establishment of Predictive Models for Nonocclusive Mesenteric Ischemia Comparing 8,296 Control with 452 Study Patients.


Journal

Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208

Informations de publication

Date de publication:
May 2019
Historique:
received: 28 05 2018
pubmed: 25 9 2018
medline: 23 8 2019
entrez: 25 9 2018
Statut: ppublish

Résumé

The aim of this study was to develop clinical preoperative, intraoperative, and postoperative scores for early identification of patients who are at risk of nonocclusive mesenteric ischemia (NOMI). A retrospective analysis. Single center. From January 2008 to December 2014, all patients from the Department of Thoracic and Cardiovascular Surgery were included on the basis of the hospital database. All mesenteric angiographically identified NOMI patients were compared with non-NOMI patients. The study population of 8,748 patients was randomized into a cohort for developing the scores (non-NOMI 4,214 and NOMI 235) and a cohort for control (non-NOMI 4,082 and NOMI 217). Risk factors were identified using forward and backward Wald test and were included in the predictive scores for the occurrence of NOMI. C statistic showed that the scores had a high discrimination for the prediction of NOMI preoperatively (C statistic 0.79; p < 0.001), intraoperatively (C statistic 0.68; p < 0.001), and postoperatively (C statistic 0.85; p < 0.001). A combination of the preoperative, intraoperative, and postoperative risk scores demonstrated the highest discrimination (C statistic 0.87; p < 0.001). The combined score included the following risk factors: renal insufficiency (preoperative); use of cardiopulmonary bypass and intra-aortic balloon pump support (intraoperative); and reexploration for bleeding, renal replacement therapy, and packed red blood cells ≥ 4 units (postoperative). The results were similar in the control group. These scores could be useful to identify patients at risk for NOMI and promote a rapid diagnosis and therapy.

Identifiants

pubmed: 30245114
pii: S1053-0770(18)30840-1
doi: 10.1053/j.jvca.2018.08.194
pii:
doi:

Types de publication

Comparative Study Journal Article Randomized Controlled Trial

Langues

eng

Pagination

1290-1297

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Hagen Bomberg (H)

Department of Thoracic and Cardiovascular Surgery, Saarland University Medical Center, Homburg/Saar, Germany; Department of Anesthesiology, Intensive Care Medicine and Pain Medicine, Saarland University Medical Center, Homburg/Saar, Germany. Electronic address: hagen.bomberg@uks.eu.

Jonas Stroeder (J)

Department of Diagnostic and Interventional Radiology, Saarland University Medical Center, Homburg/Saar, Germany.

Kathrin Karrenbauer (K)

Department of Thoracic and Cardiovascular Surgery, Saarland University Medical Center, Homburg/Saar, Germany.

Heinrich V Groesdonk (HV)

Department of Anesthesiology, Intensive Care Medicine and Pain Medicine, Saarland University Medical Center, Homburg/Saar, Germany.

Stefan Wagenpfeil (S)

Institute for Medical Biometry, Epidemiology and Medical Informatics, Saarland University Medical Center, Homburg/Saar, Germany.

Matthias Klingele (M)

Department of Medicine, Division of Nephrology and Hypertension, Saarland University Medical Center, Homburg/Saar, Germany; Department of Nephrology, Hochtaunus-Kliniken, Bad Homburg, Germany.

Arno Bücker (A)

Department of Diagnostic and Interventional Radiology, Saarland University Medical Center, Homburg/Saar, Germany.

Hans-Joachim Schäfers (HJ)

Department of Thoracic and Cardiovascular Surgery, Saarland University Medical Center, Homburg/Saar, Germany.

Peter Minko (P)

Department of Diagnostic and Interventional Radiology, Saarland University Medical Center, Homburg/Saar, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH